title: Regulation by glucocorticoids of cell differentiation and insulin-like growth factor binding protein production in cultured fetal rat nasal chondrocytes.
abstract: Glucocorticoids (GCs) modulate insulin-like growth factor action in cartilage through mechanisms that are complex and insufficiently defined, especially in the context of cranio-facial growth. Because the family of IGF-binding proteins (IGFBP-1 to -6) is important in the regulation of IGF availability and bioactivity, we examined the effect of GCs on chondrocyte differentiation in correlation with IGFBP production in cultured fetal rat chondrocytes isolated from nasal septum cartilage of fetal rat. Dexamethasone (DEX) effects were tested before and at the onset of extracellular matrix maturation. DEX induced a dose-dependent increase in the size of cartilage nodule formed, (45)Ca incorporation into extracellular matrix, alkaline phosphatase activity, and sulfatation of glycosaminoglycans, maximal effects being obtained with a 10-mM DEX concentration. The IGFBPs produced by cultured chondrocytes were characterized in culture medium which had been conditioned for 24 h under serum-free conditions by these cells. Western ligand blotting with a mixture of [(125)I]IGF-I and -II revealed bands of 20, 24, 29, a 31-32 kDa doublet and a 39-41 kDa triplet which were differently regulated by DEX. Immunoblotting showed that following DEX exposure, IGFBP-3 and -6 were up-regulated whereas IGFBP-2, -5, and the 24 kDa band were down-regulated. The effect of DEX on both differentiation and IGFBP production showed a same dependence, and developed when extracellular matrix maturation had been just induced. The results obtained in this chondrocyte culture system show that production of IGFBPs is modulated by DEX at physiological concentrations thus regulating IGF availability and action, a control which could promote the primordial role of the rat nasal septum in craniofacial growth.
authors.affiliation: Laboratoire de Biologie Oro-faciale et Pathologie, EMI 0110 INSERM, U.F.R. d'Odontologie, Université Paris 7, Institut Biomédical des Cordeliers, 15 rue de l'Ecole de Médecine, 75270 Paris Cedex 06, France.
authors.forename: Reem
authors.initials: R
authors.lastname: Nadra
authors.forename: Pierrette
authors.initials: P
authors.lastname: Menuelle
authors.forename: Sylviana
authors.initials: S
authors.lastname: Chevallier
authors.forename: Ariane
authors.initials: A
authors.lastname: Berdal
mesh_terms: D000818:Animals; D002113:Calcification, Physiologic / Q000187:drug effects; D002132:Calcium Radioisotopes; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D019902:Chondrocytes / Q000187:drug effects / Q000378:metabolism*; D003907:Dexamethasone / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005333:Fetus; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D005938:Glucocorticoids / Q000494:pharmacology*; D018969:Insulin-Like Growth Factor Binding Proteins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D009300:Nasal Septum / Q000187:drug effects* / Q000196:embryology / Q000378:metabolism; D020033:Protein Isoforms / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D002132:Calcium Radioisotopes; D005938:Glucocorticoids; D018969:Insulin-Like Growth Factor Binding Proteins; D020033:Protein Isoforms; D003907:Dexamethasone